Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Hypothyroidism (Drug Study)

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

Krisianne Mae L.

Francisco
BSN III – B (group B3)

DRUG STUDY
DRUG NAME DATE/TIME/ USES ACTION INDICATION SIDE EFFECTS NURSING RESPONSIBLITIES
FREQUENCY OF
ADMINISTRATION
Treatment Converts to T3 It is indicated for Occasional: Baseline assessment
Levothyroxine 5/08/2021 8:00am of , then binds to treatment of Reversible hair loss
hypothyro thyroid patients with at start of therapy in Obtain baseline TSH, T3 , T4 , weight, vital
Drug 50mg tab OD  idism, receptor children. signs. Signs/symptoms of diabetes, diabetes
hypothyroidism.
Classification: pituitary proteins insipidus, adrenal insufficiency,
 Thyroid thyroid- exerting Rare: Dry skin, hypopituitarism may become intensified.
hormone stimulatin metabolic GI intolerance, rash, Treat with adrenocortical steroids before
g hormone effects urticaria, thyroid therapy in coexisting hypothyroidism
Generic (TSH) through DNA pseudotumor and hypoadrenalism.
name: suppressio and protein cerebri, severe
levofloxacin n. synthesis. Intervention
headache.
Monitor pulse for rate, rhythm (report pulse
greater than 100 or marked increase).
Observe for tremors, anxiety. Assess appetite,
sleep pattern. C

Patient & Family Education

• Do not discontinue drug therapy;


replacement for hypothyroidism is lifelong.

• Follow-up office visits, thyroid function


tests are essential.
• Take medication at the same time each day,
preferably in the morning.

• Monitor pulse for rate, rhythm; report


irregular rhythm or pulse rate over 100
beats/min.

• Promptly report chest pain, weight loss,


anxiety, tremors, insomnia.

• Children may have reversible hair loss,


increased aggressiveness during first few mos
of therapy.

• Full therapeutic effect may take 1–3 wks.

You might also like